Trials / Unknown
UnknownNCT05485610
Effect of NMN (Nicotinamide Mononucleotide) on Diminished Ovarian Reserve (Including Premature Ovarian Insufficiency)
Effect of NMN (Nicotinamide Mononucleotide) Intervention on Patients With Diminished Ovarian Reserve (Including Premature Ovarian Insufficiency)
- Status
- Unknown
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 200 (estimated)
- Sponsor
- Peking University Third Hospital · Academic / Other
- Sex
- Female
- Age
- 20 Years – 40 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of the study is to understand the effect of nicotinamide mononucleotide (NMN) on patients with diminished ovarian reserve (including premature ovarian insufficiency).
Detailed description
This study aims to evaluate the effects of NMN on reproductive endocrine, immune homeostasis, and reproductive outcomes in women with DOR (including POI), and to explore its underlying mechanisms to provide the intervention strategies for DOR (including POI).
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIETARY_SUPPLEMENT | NMN intervention | NMN capsules (total of 600mg/day) for 3 months |
| OTHER | Placebo | NMN-free placebo capsules for 3 months |
Timeline
- Start date
- 2022-07-01
- Primary completion
- 2024-12-31
- Completion
- 2025-12-31
- First posted
- 2022-08-03
- Last updated
- 2022-10-12
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT05485610. Inclusion in this directory is not an endorsement.